The interpretation of trials: combined hormonal therapy and chemotherapy in disseminated breast cancer.
D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000401:mortality; D002470:Cell Survival / Q000187:drug effects; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D004965:Estrogen Antagonists / Q000008:administration & dosage* / Q000627:therapeutic use; D004967:Estrogens / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007700:Kinetics; D008593:Menopause; D010166:Palliative Care; D011372:Progestins / Q000008:administration & dosage* / Q000627:therapeutic use; D011960:Receptors, Estrogen / Q000378:metabolism; D012107:Research Design; D013629:Tamoxifen / Q000008:administration & dosage / Q000627:therapeutic use
D000970:Antineoplastic Agents; D004965:Estrogen Antagonists; D004967:Estrogens; D011372:Progestins; D011960:Receptors, Estrogen; D013629:Tamoxifen